HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fluconazole and itraconazole susceptibilities of Candida spp. isolated from oropharyngeal specimens and blood cultures of paediatric haematology/oncology patients.

Abstract
This study examined the in vitro susceptibilities to fluconazole and itraconazole of isolates of Candida spp. from surveillance oropharyngeal specimens and blood cultures from paediatric patients with malignancy. The species distribution of 100 isolates from oropharyngeal specimens was C. albicans 86%, C. glabrata 7%, C. lusitaniae 4%, C. parapsilosis 2% and C. tropicalis 1%. From a total of nine isolates from blood cultures the species distribution was C. albicans 33.3%, C. parapsilosis 33.3 % and C. guilliermondii 33.3%. Only three of the oropharyngeal isolates were resistant to fluconazole (MIC > or = 64 mg l(-1)) and only two were resistant to itraconazole (MIC > or = 1 mg l(-1)). None of the blood culture isolates was resistant to either agent. At this centre, C. albicans is the predominant species from oropharyngeal specimens, but non-albicans Candida species predominate in blood cultures. Although resistance to fluconazole and itraconazole is rare at present, continued surveillance is warranted to monitor trends in species distribution and antifungal susceptibility.
AuthorsH F Kennedy, G S Shankland, J Bagg, E A Chalmers, B E S Gibson, C L Williams
JournalMycoses (Mycoses) Vol. 49 Issue 6 Pg. 457-62 (Nov 2006) ISSN: 0933-7407 [Print] Germany
PMID17022761 (Publication Type: Journal Article)
Chemical References
  • Itraconazole
  • Fluconazole
Topics
  • Candida (drug effects, isolation & purification)
  • Candidiasis (drug therapy, etiology)
  • Fluconazole (pharmacology)
  • Fungemia (microbiology)
  • Itraconazole (pharmacology)
  • Leukemia (complications)
  • Microbial Sensitivity Tests
  • Oropharynx (microbiology)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: